Literature DB >> 5558997

Rifampin: in vitro effect on atypical mycobacteria.

T K Rynearson, J S Shronts, E Wolinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5558997     DOI： 10.1164/arrd.1971.104.2.272

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  14 in total

Review 1.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

2.  New drug regimens in the treatment of tuberculosis.

Authors:  E Wolinsky
Journal:  Bull N Y Acad Med       Date:  1975-10

3.  In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins.

Authors:  H Saito; H Tomioka; K Sato; M Emori; T Yamane; K Yamashita; K Hosoe; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

4.  Cutaneous nontuberculous mycobacterial infections.

Authors:  B J Bendl; R C Ongley
Journal:  Can Fam Physician       Date:  1978-03       Impact factor: 3.275

5.  Permeability barrier to rifampin in mycobacteria.

Authors:  J Hui; N Gordon; R Kajioka
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

6.  Pediatric antimicrobial therapy IV.

Authors:  M I Marks; R M Shapera; M Brazeau
Journal:  Can Med Assoc J       Date:  1973-08-18       Impact factor: 8.262

7.  Clinical aspects of atypical mycobacterial infection.

Authors:  L M Kahana; F M Cole; H Richardson
Journal:  Can Med Assoc J       Date:  1975-02-08       Impact factor: 8.262

8.  Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare.

Authors:  B G Yangco; E A Eikman; D A Solomon; S C Deresinski; J A Madden
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

9.  Susceptibility of mycobacteria to rifampin.

Authors:  C L Woodley; J O Kilburn; H L David; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

10.  The effect of rifampicin on Mycobacterium smegmatis.

Authors:  V Majtán; M Miko
Journal:  Folia Microbiol (Praha)       Date:  1982       Impact factor: 2.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.